Pulmonx Corporation (LUNG)
Largest Insider Buys in Sector
LUNG Stock Price History Chart
LUNG Stock Performance
About Pulmonx Corporation
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Insider Activity of Pulmonx Corporation
Over the last 12 months, insiders at Pulmonx Corporation have bought $0 and sold $1.39M worth of Pulmonx Corporation stock.
On average, over the past 5 years, insiders at Pulmonx Corporation have bought $1.11M and sold $62.59M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,700 shares for transaction amount of $9,367 was made by Lynch Alissa Hsu (director) on 2022‑11‑29.
List of Insider Buy and Sell Transactions, Pulmonx Corporation
| 2024-06-03 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 4,297 0.0112% | $6.97 | $29,950 | -9.28% | |
| 2024-06-03 | Sale | Lehman David Aaron | GENERAL COUNSEL | 5,475 0.0142% | $6.97 | $38,161 | -9.28% | |
| 2024-05-22 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 1,184 0.003% | $8.71 | $10,313 | -23.55% | |
| 2024-04-22 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 1,184 0.0031% | $7.49 | $8,868 | +1.49% | |
| 2024-03-22 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 1,184 0.0031% | $9.36 | $11,082 | -15.51% | |
| 2024-03-01 | Sale | French Glendon E. III | PRESIDENT AND CEO | 6,954 0.0175% | $9.06 | $63,003 | -10.41% | |
| 2024-03-01 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 3,097 0.0078% | $9.06 | $28,059 | -10.41% | |
| 2024-03-01 | Sale | Lehman David Aaron | GENERAL COUNSEL | 4,351 0.0109% | $9.06 | $39,420 | -10.41% | |
| 2024-03-01 | Sale | McKune John | INTERIM CFO | 1,078 0.0027% | $9.06 | $9,767 | -10.41% | |
| 2024-02-22 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 1,184 0.0037% | $14.20 | $16,813 | -29.09% | |
| 2024-02-15 | Sale | French Glendon E. III | PRESIDENT AND CEO | 20,000 0.052% | $14.60 | $292,000 | -40.67% | |
| 2024-01-22 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 1,184 0.003% | $13.13 | $15,546 | -34.06% | |
| 2024-01-18 | Sale | French Glendon E. III | PRESIDENT AND CEO | 10,000 0.026% | $12.77 | $127,700 | -31.02% | |
| 2023-12-22 | Sale | Rose Geoffrey Beran | Chief Commercial Officer | 1,184 0.0031% | $12.75 | $15,096 | -29.41% | |
| 2023-12-21 | Sale | French Glendon E. III | President and CEO | 10,000 0.0257% | $12.42 | $124,200 | -28.71% | |
| 2023-12-01 | Sale | French Glendon E. III | President and CEO | 6,676 0.0161% | $10.34 | $69,030 | -17.28% | |
| 2023-12-01 | Sale | Rose Geoffrey Beran | Chief Commercial Officer | 2,868 0.0069% | $10.34 | $29,655 | -17.28% | |
| 2023-12-01 | Sale | Lehman David Aaron | General Counsel | 3,809 0.0092% | $10.34 | $39,381 | -17.28% | |
| 2023-12-01 | Sale | McKune John | Interim CFO | 942 0.0023% | $10.34 | $9,739 | -17.28% | |
| 2023-11-22 | Sale | Rose Geoffrey Beran | Chief Commercial Officer | 1,184 0.0031% | $10.60 | $12,550 | -12.12% |
Insider Historical Profitability
| French Glendon E. III | PRESIDENT AND CEO | 1116758 2.9794% | $6.14 | 0 | 31 | |
| Sung Derrick | Chief Financial Officer | 391041 1.0208% | $6.14 | 0 | 15 | |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 301203 0.6375% | $6.14 | 0 | 32 | |
| Lehman David Aaron | General Counsel | 209113 0.3911% | $6.14 | 0 | 12 | |
| McKune John | Interim CFO | 47410 0.1055% | $6.14 | 0 | 2 | |
| BOSTON SCIENTIFIC CORP | 10 percent owner | 1488106 3.8846% | $6.14 | 0 | 3 | |
| Ferrari Richard | director | 30035 0.0784% | $6.14 | 3 | 0 | +64.56% |
| Mead Dana G Jr. | director | 26315 0.0687% | $6.14 | 1 | 0 | <0.0001% |
| Melenikiotou Georgia | director | 26315 0.0687% | $6.14 | 1 | 0 | <0.0001% |
| Lynch Alissa Hsu | director | 11910 0.0311% | $6.14 | 1 | 0 | +101.97% |
| Florin Daniel P | director | 7532 0.0197% | $6.14 | 3 | 0 | <0.0001% |
Institutional Investor Ownership
| PRIMECAP Management Co | $53.2M | 14.79 | 5.74M | +1.65% | +$861,887.52 | 0.04 | |
| Fidelity Investments | $45M | 12.51 | 4.85M | +46.67% | +$14.32M | <0.01 | |
| BlackRock | $28.16M | 7.83 | 3.04M | -2.56% | -$739,718.17 | <0.01 | |
| Point72 Asset Management | $25.17M | 7 | 2.72M | +75.61% | +$10.84M | 0.05 | |
| Morgan Stanley | $24.58M | 6.83 | 2.65M | +16.36% | +$3.46M | <0.01 | |
| The Vanguard Group | $19.26M | 5.35 | 2.08M | +0.55% | +$105,835.59 | <0.0001 | |
| State Street | $9.04M | 2.51 | 974,680 | +11.4% | +$924,358.09 | <0.0001 | |
| Geode Capital Management | $7.74M | 2.15 | 834,524 | +3.47% | +$259,777.71 | <0.01 | |
| Victory Capital Management Inc | $7.66M | 2.13 | 826,297 | -3.23% | -$255,379.26 | 0.01 | |
| Braidwell Lp | $6.98M | 1.94 | 752,541 | -4.49% | -$328,278.51 | 0.39 | |
| Franklin Templeton Investments | $6.64M | 1.85 | 716,717 | -3.46% | -$238,192.56 | <0.01 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $6.05M | 1.68 | 652,400 | 0% | +$0 | 0.15 | |
| Millennium Management LLC | $6.03M | 1.68 | 650,234 | -19.13% | -$1.43M | <0.01 | |
| Deutsche Bank | $4.83M | 1.34 | 521,084 | -0.68% | -$33,149.52 | <0.01 | |
| Pura Vida Investments LLC | $4.33M | 1.2 | 466,787 | -2.22% | -$98,363.96 | 3.08 | |
| D. E. Shaw & Co. | $4M | 1.11 | 431,297 | -30.73% | -$1.77M | 0.01 | |
| Dimensional Fund Advisors | $3.67M | 1.02 | 395,723 | +2.85% | +$101,525.03 | <0.01 | |
| Northern Trust | $3.04M | 0.85 | 328,322 | -2.07% | -$64,287.45 | <0.01 | |
| Charles Schwab | $2.79M | 0.78 | 301,372 | +4.15% | +$111,379.03 | <0.01 | |
| Renaissance Technologies | $2.47M | 0.69 | 266,610 | +36.61% | +$662,186.48 | <0.01 | |
| JPMorgan Chase | $2.45M | 0.68 | 264,575 | +406.24% | +$1.97M | <0.0001 | |
| Cfm Wealth Partners Llc | $2.45M | 0.68 | 264,039 | 0% | +$0 | 0.49 | |
| Jefferies Financial Group | $2.18M | 0.61 | 235,110 | -17.54% | -$463,500.06 | 0.04 | |
| Boothbay Fund Management LLC | $2.1M | 0.58 | 226,199 | +737.77% | +$1.85M | 0.07 | |
| Goldman Sachs | $1.99M | 0.55 | 214,612 | -14.98% | -$350,424.50 | <0.0001 | |
| Divisadero Street Capital Management Lp | $1.93M | 0.54 | 208,473 | -85.18% | -$11.11M | 0.45 | |
| Jacobs Levy Equity Management | $1.83M | 0.51 | 197,336 | -45.91% | -$1.55M | 0.01 | |
| Millrace Asset Group, Inc. | $1.78M | 0.49 | 191,580 | New | +$1.78M | 1.84 | |
| Two Sigma Advisers LP | $1.46M | 0.41 | 157,500 | -21.64% | -$403,245.00 | <0.01 | |
| Nuveen | $1.43M | 0.4 | 154,664 | -26.52% | -$517,349.33 | <0.0001 | |
| BNY Mellon | $1.3M | 0.36 | 140,162 | -8.71% | -$123,930.65 | <0.0001 | |
| Citadel Advisors LLC | $1.24M | 0.34 | 133,263 | +142.6% | +$726,137.63 | <0.01 | |
| Marshall Wace | $1.14M | 0.32 | 123,313 | +45.44% | +$357,136.17 | <0.01 | |
| Tudor Investment Corp Et Al | $1.11M | 0.31 | 119,470 | +128.23% | +$622,230.27 | 0.01 | |
| Barclays | $1.05M | 0.29 | 112,808 | -17.85% | -$227,312.69 | <0.0001 | |
| Two Sigma | $845,748.00 | 0.24 | 91,235 | -46% | -$720,324.97 | <0.01 | |
| SEI Investments Company | $673,243.00 | 0.19 | 72,626 | +2.54% | +$16,686.00 | <0.01 | |
| PDT Partners | $651,588.00 | 0.18 | 70,290 | +122.46% | +$358,683.95 | 0.05 | |
| Swiss National Bank | $625,725.00 | 0.17 | 67,500 | 0% | +$0 | <0.0001 | |
| Susquehanna International Group | $573,721.00 | 0.16 | 61,890 | +245.47% | +$407,648.75 | <0.01 | |
| Abg Wtt Global Life Science Capital Partners Gp Ltd | $558,091.00 | 0.16 | 60,204 | 0% | +$0 | 1.34 | |
| AQR Capital | $553,697.00 | 0.15 | 59,730 | +72.3% | +$232,343.24 | <0.01 | |
| Algert Global LLC | $533,000.00 | 0.15 | 57,503 | -36.1% | -$301,152.46 | 0.02 | |
| RhumbLine Advisers | $487,982.00 | 0.14 | 52,642 | +3.41% | +$16,073.87 | <0.0001 | |
| Cibc World Markets Corp | $463,500.00 | 0.13 | 50,000 | New | +$463,500.00 | <0.01 | |
| Credit Suisse | $446,137.00 | 0.12 | 48,127 | +5.09% | +$21,608.36 | <0.0001 | |
| UBS | $438,842.00 | 0.12 | 47,340 | +40.58% | +$126,674.61 | <0.0001 | |
| Cubist Systematic Strategies | $418,632.00 | 0.12 | 45,160 | New | +$418,632.00 | <0.01 | |
| Engineers Gate Manager Lp | $417,882.00 | 0.12 | 45,079 | +72.83% | +$176,092.78 | 0.01 | |
| Balyasny Asset Management Llc | $414,109.00 | 0.12 | 44,672 | New | +$414,109.00 | <0.01 |